查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2104597

免疫比濁法試劑市場：依測試類型、應用、最終用戶、國家及地區分類－全球產業分析、市場規模、市佔率及2026年至2033年預測

Immunoturbidimetry Reagents Market, By Test Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 314 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，免疫比濁試劑市場規模將達到 13.062 億美元，並將在 2026 年至 2033 年以 6.9% 的複合年成長率成長。

免疫比濁法試劑市場包含用於免疫比濁法的試劑。免疫比濁法是一種利用抗體與目標抗原反應產生的濁度來定量特定蛋白質或生物標記含量的檢測法。這些試劑廣泛應用於臨床化學分析儀中，用於測量C反應蛋白（CRP）、免疫球蛋白、補體蛋白、載脂蛋白、糖化血紅蛋白（HbA1c）以及其他與感染疾病、心臟病、自體免疫疾病、糖尿病和腎臟病相關的生物標記的濃度。

推動該產業成長的因素包括慢性疾病患者數量的增加、對快速自動化診斷需求的成長、臨床檢查室基礎設施的擴建以及高通量臨床化學分析儀的廣泛應用。此外，試劑配方、檢查室自動化技術和診斷程序的不斷進步，以及醫療保健成本的上升和健康體檢宣傳活動的開展，預計也將推動未來幾年全球免疫比濁試劑市場的成長。

免疫比濁法試劑市場－市場動態

慢性疾病和感染疾病負擔的加重推動了免疫比濁試劑市場的成長。

預計慢性病和感染疾病的日益普遍將推動預測期內市場擴張。特別是，免疫比濁法因其能夠定量檢測多種生物標記（例如C反應蛋白（CRP）、免疫球蛋白、補體蛋白、載脂蛋白和糖化血紅蛋白（HbA1c））而備受臨床檢查室關注。這項技術使醫護人員能夠及早發現和監測多種疾病，包括心血管疾病、糖尿病、自體免疫疾病、腎臟疾病和細菌感染疾病，從而透過及時干預改善患者預後。根據世界衛生組織統計，非傳染性疾病（NCDs）每年在全球造成約4,100萬人死亡，約佔所有死亡人數的74%。

各國政府和醫療機構加大對診斷檢測設施的投資，以及高通量分析儀的普及，正在推動免疫比濁試劑在全球的擴張。此外，旨在提高靈敏度和標準化各種免疫比濁測量方案的持續研發活動，也將積極促進該行業的整體成長。隨著越來越多的人尋求經濟高效的解決方案和快速的檢測結果，這一趨勢表明，市場對能夠準確測量多種關鍵蛋白標記物的快速檢測平台的需求將持續成長，預計這將進一步推動免疫比濁試劑領域的擴張。

免疫比濁測量試劑市場－市場區隔分析：

全球免疫比濁試劑市場按測試類型、應用、最終用戶和地區進行細分。

在免疫比濁試劑市場中，C反應蛋白（CRP）試劑在檢測類型細分市場中佔據最大的市場佔有率。這主要歸功於CRP檢測在發炎性疾病、細菌感染疾病、心臟病和自體免疫疾病的診斷和後續觀察中的廣泛應用。 CRP免疫比濁檢測通常使用自動化臨床化學分析儀進行，因為它能夠提供高度可重複、快速且準確的定量結果。例如，羅氏於2025年3月在其cobas®臨床化學分析儀產品組合中推出了Tina-quant®脂蛋白(a) Gen.2免疫比濁法檢測。 Tina-quant®脂蛋白(a) Gen.2檢測旨在透過在臨床檢查室中提供可靠的脂蛋白(a)檢測來改善心臟病風險評估。此次發布表明，用於自動化臨床化學分析的免疫比濁試劑正在不斷發展。同時，由於糖尿病盛行率的不斷上升，預計HbA1c試劑在未來幾年將迎來顯著成長。

按應用領域分類，臨床化學佔據最大的市場佔有率，這主要得益於免疫比濁法在常規診斷檢查室中用於測量蛋白質標記的廣泛應用。由於慢性病負擔日益加重以及對自動化臨床檢測需求的成長，預計心血管疾病檢測、自體免疫傳染病檢查、傳染病檢測、糖尿病檢測和腎臟疾病檢測的需求將會增加。按終端用戶分類，醫院檢查室是主要終端用戶，這主要歸功於其龐大的患者數量、自動化設備的廣泛應用以及對臨床診斷設施投入的增加。預計未來幾年，獨立診斷實驗室、學術和研究機構以及專科診所也將保持穩定成長。

免疫比濁試劑市場—區域分析

在免疫比濁試劑市場，北美佔據最大的市場佔有率，這得益於其完善的醫療保健基礎設施、自動化臨床化學分析儀的廣泛應用、大量的診斷檢測以及眾多大型體外診斷（IVD）公司的存在。其他因素包括慢性病發病率的上升以及檢查室設備升級的持續投入。根據美國疾病管制與預防中心（CDC）發布的報告，美國十分之六的成年人至少患有一種慢性病，十分之四的成年人患有兩種或兩種以上的慢性病。慢性病盛行率的上升推動了對C反應蛋白（CRP）、糖化血紅蛋白（HbA1c）、免疫球蛋白和載脂蛋白等生物標記檢測的需求，進而推動了免疫比濁試劑的應用。

歐洲也是一個重要的市場，這得益於其完善的臨床實驗室網路、優惠的報銷機制以及政府對疾病預防和早期診斷的持續投入。據歐盟委員會稱，歐盟健康計畫（EU4Health，2021-2027）撥款53億歐元，用於加強歐盟成員國的醫療保健系統、改善疾病預防並提升診斷能力。該計劃鼓勵醫療服務提供者擴大其使用先進臨床實驗室和自動化診斷技術的管道，從而在歐洲範圍內提高免疫比濁法在心血管疾病、感染疾病、自體免疫疾病和代謝性疾病檢測中的應用。

目錄

第1章：免疫比濁法測定試劑市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：免疫比濁法測定試劑的主要市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：免疫比濁法測定試劑的工業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：免疫比濁測量試劑市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：免疫比濁法測定試劑的市場趨勢

  • 2025年免疫比濁試劑市佔率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章：免疫比濁法試劑市場：依檢測類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按測試類型
    • C反應蛋白（CRP）試劑
    • 免疫球蛋白試劑
    • 補體系統試劑
    • 載脂蛋白試劑
    • HbA1c試劑
    • 其他

第8章：免疫比濁法測定試劑市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 臨床化學
    • 自體免疫疾病檢測
    • 心血管疾病檢查
    • 傳染病檢查
    • 糖尿病檢測
    • 腎臟科檢查
    • 其他

第9章：免疫比濁法測定試劑市場：依最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 醫院實驗室
    • 獨立診斷實驗室
    • 學術研究機構
    • 專科診所
    • 其他

第10章：免疫比濁法試劑市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章：主要供應商分析：免疫比濁試劑產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Siemens Healthineers AG
    • Beckman Coulter, Inc.（Danaher Corporation）
    • Thermo Fisher Scientific Inc.
    • DiaSys Diagnostic Systems GmbH
    • Randox Laboratories Ltd.
    • HORIBA, Ltd.
    • Sekisui Diagnostics
    • Sentinel Diagnostics Srl
    • FUJIFILM Wako Pure Chemical Corporation
    • BioSystems SA
    • Mindray Bio-Medical Electronics Co., Ltd.
    • Tosoh Corporation
    • Shenzhen Dirui Industrial Co., Ltd.
    • HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
    • Trinity Biotech plc
    • DiaSorin SpA
    • QuidelOrtho Corporation
    • BUHLMANN Laboratories AG
    • Werfen
    • Zybio Inc.
    • Maccura Biotechnology Co., Ltd.
    • Beijing Strong Biotechnologies, Inc.
    • Shanghai Kehua Bio-Engineering Co., Ltd.
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7034

Immunoturbidimetry Reagents Market size was valued at US$ 1,306.2 Million in 2025, expanding at a CAGR of 6.9% from 2026 to 2033.

Immunoturbidimetry Reagents Market consists of reagents that are employed in immunoturbidimetric tests where the turbidity produced from the reaction between antibodies and targeted antigens helps in quantifying the number of specific proteins and biomarkers. These reagents are extensively applied in clinical chemistry analyzers to determine the levels of C-Reactive Protein (CRP), immunoglobulins, complement proteins, apolipoproteins, HbA1c, and various other biomarkers linked to infectious diseases, heart diseases, autoimmune disorders, diabetes, and renal diseases.

The growth of this industry is being augmented by factors such as growing number of patients with chronic diseases, increasing demand for quick and automated diagnostics, expanding base of clinical laboratories, and increased use of high-throughput clinical chemistry analyzers. Additionally, constant developments in reagent formulations, laboratory automation technology, and diagnostic procedures, along with high healthcare expenditure and health screening campaigns, are projected to fuel the growth of global Immunoturbidimetry Reagents Market over the coming years.

Immunoturbidimetry Reagents Market- Market Dynamics

Rising Burden of Chronic and Infectious Diseases Drives Immunoturbidimetry Reagents Market Growth

The rising prevalence of both chronic and infectious diseases is anticipated to fuel market expansion during the forecast period. In particular, Immunoturbidimetric assays have gained significant traction in Clinical Laboratories due to their ability to quantify various Biomarkers such as C- reactive Protein (CRP), Immunoglobulins, Complement Proteins, Apolipoproteins, & HbA1c. This technique enables medical professionals to detect and monitor numerous conditions ranging from Cardiovascular Diseases, Diabetes Mellitus, Autoimmune Disorders, Renal Diseases, Bacterial Infections etc. at an early stage leading to improved patient outcomes through timely interventions. According to WHO statistics, noncommunicable diseases (NCDs) accounts for about 41 million deaths every year globally which constitutes around 74% of total mortality rates.

Increased investment by governments/healthcare Institutions towards diagnostic laboratory infrastructure expansion coupled with widespread adoption of High Throughput Analyzers has catalyzed greater utilization of immunoturbidimetry reagents on a global scale. Moreover, ongoing R&D activities aimed at enhancing sensitivity levels and standardizing various immunoturbidimetric protocols will contribute positively towards overall industry growth trajectory. With more people seeking fast track results accompanied by cost effective solutions, this trend indicates that there will be continued demand for rapid testing platforms capable delivering accurate readings pertaining several key protein markers prompting further expansion plans within immunoturbidimetry reagents sector.

Immunoturbidimetry Reagents Market- Segmentation Analysis:

The Global Immunoturbidimetry Reagents Market is segmented on the basis of Test Type, Application, End User, and Region.

The Immunoturbidimetry Reagents Market includes C-Reactive Protein (CRP) Reagents in the Test Type segment as the dominant market share, attributed to the extensive utilization of CRP tests for diagnosing and monitoring inflammatory diseases, bacterial infections, heart diseases, and autoimmunity. The CRP immunoturbidimetric tests are conducted using automated clinical chemistry analyzers since they yield rapid and accurate quantitative results that are highly reproducible. For example, in March 2025, Roche launched the Tina-quant(R) Lipoprotein (a) Gen.2 immunoturbidimetric assay on the cobas(R) clinical chemistry analyzer portfolio. The Tina-quant(R) Lipoprotein (a) Gen.2 assay aims to enhance the risk assessment of heart diseases by offering reliable Lipoprotein (a) testing in clinical laboratories. This launch shows the continuous development of immunoturbidimetric reagents for automated clinical chemistry analysis. On the other hand, HbA1c Reagents are forecasted to experience significant growth in the coming years due to the rising incidence of diabetes.

Based on Application, Clinical Chemistry enjoys the largest market share due to the increased use of immunoturbidimetric methods for protein markers in routine diagnostics laboratories. Cardiovascular Disease Testing, Autoimmune Disease Testing, Infectious Disease Testing, Diabetes Testing, and Nephrology Testing are expected to enjoy an increase in demand due to the increasing burden of chronic conditions and growing demand for automated laboratory diagnostics. Based on End User, Hospital Laboratories are the major end users due to high patient throughput, availability of automated instruments, and growing investment in clinical diagnostics facilities. The Independent Diagnostic Laboratories, Academic & Research Institutes, and Specialty Clinics will also expected to steady growth in the coming years.

Immunoturbidimetry Reagents Market- Geographical Insights

In Immunoturbidimetry Reagents Market, North America holds the largest market share due to their superior healthcare infrastructure, use of automated clinical chemistry analyzers, diagnostic test volume and presence of major IVD companies. Other factors include increased occurrence of chronic diseases and constant investment in upgrading laboratories. As per the reports published by Centers for Disease Control and Prevention (CDC), six out of ten American adults suffer from at least one chronic disease, while four out of ten suffer from two or more chronic diseases. The rise in prevalence of chronic diseases is fueling the demand for biomarkers, such as CRP, HbA1c, immunoglobulin, and apolipoprotein tests and, thus, driving the adoption of immunoturbidimetry reagents.

Europe represents another significant market, supported by well-established clinical laboratory networks, favorable healthcare reimbursement systems, and increasing government investments in disease prevention and early diagnosis. According to the European Commission, the EU4Health Programme (2021-2027) has allocated €5.3 billion to strengthen healthcare systems, improve disease prevention, and enhance diagnostic capabilities across European Union member states. The program is encouraging healthcare providers to expand access to advanced clinical laboratory testing and automated diagnostic technologies, thereby increasing the utilization of immunoturbidimetric assays for cardiovascular, infectious, autoimmune, and metabolic disease testing across the region.

Immunoturbidimetry Reagents Market- Competitive Landscape:

The competitive landscape of Immunoturbidimetry Reagents Market involves the operation of leading IVD companies engaged in innovations in products, assay standardizations, and development of portfolio of automated clinical chemistry tests. Major competitors of the market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Beckman Coulter, Inc. (Danaher Corporation), DiaSys Diagnostic Systems GmbH, Randox Laboratories Ltd., HORIBA, Ltd., Sekisui Diagnostics, Sentinel Diagnostics S.r.l., and FUJIFILM Wako Pure Chemical Corporation. Competition in the market is being witnessed in the form of development of new reagents, collaborations, approvals, and development of assays that are compatible with analyzers. The continuous development in high sensitivity immunoturbidimetric reagents, laboratory automation, and clinical chemistry systems is helping manufacturers to gain strong positions in the market.

Recent Developments:

In March 2025, Medical & Biological Laboratories (MBL) entered a licensing agreement with Agappe Diagnostics to transfer latex immunoturbidimetric reagent manufacturing technology and supply IVD raw materials. The partnership enabled Agappe to manufacture high-quality latex reagents in India, strengthening domestic diagnostic capabilities while supporting standardized and cost-effective clinical testing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Beckman Coulter, Inc. (Danaher Corporation)
  • Thermo Fisher Scientific Inc.
  • DiaSys Diagnostic Systems GmbH
  • Randox Laboratories Ltd.
  • HORIBA, Ltd.
  • Sekisui Diagnostics
  • Sentinel Diagnostics S.r.l.
  • FUJIFILM Wako Pure Chemical Corporation
  • BioSystems S.A.
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Tosoh Corporation
  • Shenzhen Dirui Industrial Co., Ltd.
  • HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
  • Trinity Biotech plc
  • DiaSorin S.p.A.
  • QuidelOrtho Corporation
  • BUHLMANN Laboratories AG
  • Werfen
  • Zybio Inc.
  • Maccura Biotechnology Co., Ltd.
  • Beijing Strong Biotechnologies, Inc.
  • Shanghai Kehua Bio-Engineering Co., Ltd.
  • Others

GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2020 - 2033

  • C-Reactive Protein (CRP) Reagents
  • Immunoglobulin Reagents
  • Complement System Reagents
  • Apolipoprotein Reagents
  • HbA1c Reagents
  • Others

GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Clinical Chemistry
  • Autoimmune Disease Testing
  • Cardiovascular Disease Testing
  • Infectious Disease Testing
  • Diabetes Testing
  • Nephrology Testing
  • Others

GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Hospital Laboratories
  • Independent Diagnostic Laboratories
  • Academic & Research Institutes
  • Specialty Clinics
  • Others

GLOBAL IMMUNOTURBIDIMETRY REAGENTS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Immunoturbidimetry Reagents Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immunoturbidimetry Reagents Market Snippet by Test Type
    • 2.1.2. Immunoturbidimetry Reagents Market Snippet by Application
    • 2.1.3. Immunoturbidimetry Reagents Market Snippet by End User
    • 2.1.4. Immunoturbidimetry Reagents Market Snippet by Country
    • 2.1.5. Immunoturbidimetry Reagents Market Snippet by Region
  • 2.2. Competitive Insights

3. Immunoturbidimetry Reagents Key Market Trends

  • 3.1. Immunoturbidimetry Reagents Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immunoturbidimetry Reagents Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immunoturbidimetry Reagents Market Opportunities
  • 3.4. Immunoturbidimetry Reagents Market Future Trends

4. Immunoturbidimetry Reagents Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immunoturbidimetry Reagents Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Immunoturbidimetry Reagents Market Landscape

  • 6.1. Immunoturbidimetry Reagents Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immunoturbidimetry Reagents Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2025 & 2033 (%)
    • 7.1.2. C-Reactive Protein (CRP) Reagents
    • 7.1.3. Immunoglobulin Reagents
    • 7.1.4. Complement System Reagents
    • 7.1.5. Apolipoprotein Reagents
    • 7.1.6. HbA1c Reagents
    • 7.1.7. Others

8. Immunoturbidimetry Reagents Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Clinical Chemistry
    • 8.1.3. Autoimmune Disease Testing
    • 8.1.4. Cardiovascular Disease Testing
    • 8.1.5. Infectious Disease Testing
    • 8.1.6. Diabetes Testing
    • 8.1.7. Nephrology Testing
    • 8.1.8. Others

9. Immunoturbidimetry Reagents Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Hospital Laboratories
    • 9.1.3. Independent Diagnostic Laboratories
    • 9.1.4. Academic & Research Institutes
    • 9.1.5. Specialty Clinics
    • 9.1.6. Others

10. Immunoturbidimetry Reagents Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Immunoturbidimetry Reagents Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Immunoturbidimetry Reagents Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Immunoturbidimetry Reagents Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Immunoturbidimetry Reagents Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Immunoturbidimetry Reagents Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Immunoturbidimetry Reagents Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd.
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Siemens Healthineers AG
    • 11.2.4. Beckman Coulter, Inc. (Danaher Corporation)
    • 11.2.5. Thermo Fisher Scientific Inc.
    • 11.2.6. DiaSys Diagnostic Systems GmbH
    • 11.2.7. Randox Laboratories Ltd.
    • 11.2.8. HORIBA, Ltd.
    • 11.2.9. Sekisui Diagnostics
    • 11.2.10. Sentinel Diagnostics S.r.l.
    • 11.2.11. FUJIFILM Wako Pure Chemical Corporation
    • 11.2.12. BioSystems S.A.
    • 11.2.13. Mindray Bio-Medical Electronics Co., Ltd.
    • 11.2.14. Tosoh Corporation
    • 11.2.15. Shenzhen Dirui Industrial Co., Ltd.
    • 11.2.16. HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
    • 11.2.17. Trinity Biotech plc
    • 11.2.18. DiaSorin S.p.A.
    • 11.2.19. QuidelOrtho Corporation
    • 11.2.20. BUHLMANN Laboratories AG
    • 11.2.21. Werfen
    • 11.2.22. Zybio Inc.
    • 11.2.23. Maccura Biotechnology Co., Ltd.
    • 11.2.24. Beijing Strong Biotechnologies, Inc.
    • 11.2.25. Shanghai Kehua Bio-Engineering Co., Ltd.
    • 11.2.26. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us